Results 221 to 230 of about 22,335 (252)

Steatotic liver disease, MASLD and risk of chronic kidney disease

open access: yesDiabetes and Metabolism
With the rising tide of fatty liver disease related to metabolic dysfunction worldwide, the association of this common liver disease with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the old term non-alcoholic fatty ...
Christopher D Byrne   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease

Hepatology International
In 2023, a new nomenclature of "metabolic associated steatotic liver disease" (MASLD) has emerged by incorporating cardio-metabolic criteria to redefine "non-alcoholic fatty liver disease" (NAFLD). Among steatotic liver disease (SLD), those having no known causes and without any one of cardio-metabolic criteria are deemed to have cryptogenic SLD.
Shao-Wen Wang   +4 more
openaire   +2 more sources

Detecting at-risk steatotic liver disease and liver fibrosis in the community

Hepatology
Advanced liver fibrosis and “At-Risk” metabolic dysfunction-associated steatohepatitis (At-Risk MASH) are present in 5% and 10%, respectively, of community-based patients with steatotic liver disease and metabolic risk factors and/or excess alcohol consumption.
Leon A. Adams   +2 more
openaire   +2 more sources

Precision medicine in steatotic liver disease

Current Opinion in Gastroenterology
Purpose of review Discuss advances in genomics, metabolomics, and proteomics in steatotic liver disease. Recent findings Common genetic variants in genes including PNPLA3
Vitchapong Prasitsumrit, Vincent L. Chen
openaire   +1 more source

Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments

International Journal of Molecular Sciences, 2023
Hidekatsu Yanai   +2 more
exaly  

Steatotic liver disease

2010
Yuranga Weerakkody   +2 more
openaire   +1 more source

Lipid droplets in steatotic liver disease [PDF]

open access: possible
Purpose of review: this review aims to discuss the most recent evidence exploring the role of lipid droplets in steatotic liver disease (SLD). We highlight the breadth of mechanisms by which lipid droplets may contribute to the progression of SLD with a particular focus on the role of lipid droplets as inducers of mechanical stress within hepatocytes ...
Bilson, Josh, Scorletti, Eleonora
openaire   +1 more source

Mechanisms of liver regeneration and their relevance to steatotic liver disease

American Journal of Physiology-Gastrointestinal and Liver Physiology
Gary Huang, V. Nathan Subramaniam
openaire   +2 more sources

Home - About - Disclaimer - Privacy